| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.6M | +8.4% |
| SG&A Expense | $4.6M | +11.0% |
| Operating Income | -$11.3M | +22.4% |
| Income Tax | $0 | — |
| Net Income | -$11.7M | -11.5% |
| EPS (Basic) | -$15.79 | -1511.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | +45.5% |
| Total Assets | $2.7M | +44.4% |
| Current Liabilities | $816K | -31.8% |
| Total Liabilities | $816K | -31.8% |
| Stockholders' Equity | $2.8M | +76.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.0M | +4.5% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $9.8M | +30.7% |